Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases.

Preclinical studies have identified and validated tumour necrosis factor alpha (TNFalpha) as a key disease molecule and therapeutic target for immunotherapeutic intervention in many immune-mediated inflammatory diseases. Clinical indications include rheumatoid arthritis, Crohn's disease, ankylo...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Taylor, P, Williams, R, Feldmann, M
Aineistotyyppi: Journal article
Kieli:English
Julkaistu: 2004

Samankaltaisia teoksia